Buscar resultados de ensayos clínicos

Patrocinado por

Primary Myelofibrosis - 13 Studies Found

Estado Estudiar
Terminated Nombre del estudio: A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)
Condición: Primary Myelofibrosis
Fecha: 2014-03-06
Intervenciones: Drug: Ruxolitinib Starting dose was based on reason for previous discontinuation of ruxolitinib (i.e. lo
Completed Nombre del estudio: Thalidomide in Treating Patients With Myelofibrosis
Condición: Primary Myelofibrosis
Fecha: 2001-05-06
Intervenciones:
  • Drug: thalidomide Given PO
Withdrawn Nombre del estudio: A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis
Condición: Primary Myelofibrosis
Fecha: 2015-10-21
Intervenciones: Biological: Pacritinib QD (Once a day)
Active, not recruiting Nombre del estudio: Decitabine in Treating Patients With Myelofibrosis
Condición:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Fecha: 2004-11-09
    Intervenciones:
    • Drug: Decitabine Given SC
Recruiting Nombre del estudio: P1101 in Treating Patients With Myelofibrosis
Condición:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Fecha: 2015-02-17
    Intervenciones:
    • Other: Laboratory Biomarker Analysis

Active, not recruiting Nombre del estudio: Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Condición: Primary Myelofibrosis
Fecha: 2010-07-15
Intervenciones:
  • Drug: Pomalidomide 0.5 mg Poma
Completed Nombre del estudio: Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
Condición:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Fecha: 2016-09-26
    Intervenciones:
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed Nombre del estudio: A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
Condición: Primary Myelofibrosis (MF)
Fecha: 2014-03-12
Intervenciones: Drug: Ruxolitinib
Recruiting Nombre del estudio: JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
Condición:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Fecha: 2014-09-12
    Intervenciones:
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed Nombre del estudio: A Phase 2 Study With IPI-926 in Patients With Myelofibrosis
Condición:
  • Primary Myelofibrosis
  • Fibrosis, Bone Marrow

Fecha: 2011-06-09
Intervenciones: Drug: IPI-926 Single Arm study of oral IPI-926 at 160 mg, 130 mg or 110 mg daily, until progressive dise
Next >>>